TTM
$2.76B
YoY change
+11.8%
5Y CAGR
+11.1%
Peak year (2025)
$2.66B
Cumulative gross profit
$26.77B
Gross Profit history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $2.66B
Gross Profit growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: +11.8%
Gross Profit history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $2.66B | +11.8% | +$280.65M | ||
| 2024 | $2.38B | +8.6% | +$188.96M | ||
| 2023 | $2.19B | +9.3% | +$185.63M | ||
| 2022 | $2.00B | +6.1% | +$114.91M | ||
| 2021 | $1.89B | +20.3% | +$318.39M | ||
| 2020 | $1.57B | +15.0% | +$205.49M | ||
| 2019 | $1.37B | +10.0% | +$124.01M | ||
| 2018 | $1.24B | +13.1% | +$144.16M | ||
| 2017 | $1.10B | +12.5% | +$121.95M | ||
| 2016 | $975.44M | +9.6% | +$85.17M | ||
| 2015 | $890.27M | +9.1% | +$74.15M | ||
| 2014 | $816.12M | +7.9% | +$60.00M | ||
| 2013 | $756.12M | +8.1% | +$56.97M | ||
| 2012 | $699.15M | +8.1% | +$52.64M | ||
| 2011 | $646.51M | +11.7% | +$67.88M | ||
| 2010 | $578.62M | +9.9% | +$52.34M | ||
| 2009 | $526.28M | -0.7% | −$3.48M | ||
| 2008 | $529.77M | +14.3% | +$66.24M | ||
| 2007 | $463.52M | +22.1% | +$83.99M | ||
| 2006 | $379.53M | +17.5% | +$56.63M | ||
| 2005 | $322.90M | +15.7% | +$43.88M | ||
| 2004 | $279.02M | +21.2% | +$48.71M | ||
| 2003 | $230.30M | +19.5% | +$37.58M | ||
| 2002 | $192.72M | +5.1% | +$9.39M | ||
| 2001 | $183.33M | -6.8% | −$13.33M | ||
| 2000 | $196.66M | +2.8% | +$5.36M | ||
| 1999 | $191.30M | +7.7% | +$13.60M | ||
| 1998 | $177.70M | +24.1% | +$34.50M | ||
| 1997 | $143.20M | -13.1% | −$21.60M | ||
| 1996 | $164.80M | +45.3% | +$51.40M | ||
| 1995 | $113.40M | +45.9% | +$35.70M | ||
| 1994 | $77.70M | +31.9% | +$18.80M | ||
| 1993 | $58.90M | +63.6% | +$22.90M | ||
| 1992 | $36.00M | +92.5% | +$17.30M | ||
| 1991 | $18.70M | — | — |
- 2025$2.66B+11.8%
- 2024$2.38B+8.6%
- 2023$2.19B+9.3%
- 2022$2.00B+6.1%
- 2021$1.89B+20.3%
- 2020$1.57B+15.0%
- 2019$1.37B+10.0%
- 2018$1.24B+13.1%
- 2017$1.10B+12.5%
- 2016$975.44M+9.6%
- 2015$890.27M+9.1%
- 2014$816.12M+7.9%
- 2013$756.12M+8.1%
- 2012$699.15M+8.1%
- 2011$646.51M+11.7%
- 2010$578.62M+9.9%
- 2009$526.28M-0.7%
- 2008$529.77M+14.3%
- 2007$463.52M+22.1%
- 2006$379.53M+17.5%
- 2005$322.90M+15.7%
- 2004$279.02M+21.2%
- 2003$230.30M+19.5%
- 2002$192.72M+5.1%
- 2001$183.33M-6.8%
- 2000$196.66M+2.8%
- 1999$191.30M+7.7%
- 1998$177.70M+24.1%
- 1997$143.20M-13.1%
- 1996$164.80M+45.3%
- 1995$113.40M+45.9%
- 1994$77.70M+31.9%
- 1993$58.90M+63.6%
- 1992$36.00M+92.5%
- 1991$18.70M—
Gross Profit values are taken from IDEXX Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's current gross profit (TTM) is $2.76B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, IDEXX Laboratories (IDXX) reported gross profit of $2.66B – grew 11.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories gross profit compounded at +11.1% per year, sustaining 16 straight years of year-over-year growth.
The highest annual gross profit of $2.66B was reported in 2025. The lowest in the available history was $18.70M in 1991.
IDEXX Laboratories Gross Profit by Year
IDEXX Laboratories Gross Profit 2025: $2.66B
In 2025, IDEXX Laboratories reported gross profit of $2.66B, grew 11.8% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Gross Profit 2024: $2.38B
IDEXX Laboratories gross profit in 2024 was $2.38B, grew 8.6% from 2023.
IDEXX Laboratories Gross Profit 2023: $2.19B
2023's gross profit for IDEXX Laboratories came in at $2.19B, grew 9.3% from 2022.
IDEXX Laboratories Gross Profit 2022: $2.00B
IDEXX Laboratories posted gross profit of $2.00B in 2022, grew 6.1% from 2021.
IDEXX Laboratories Gross Profit 2021: $1.89B
IDEXX Laboratories gross profit in 2021 was $1.89B.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by Gross Profit
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation